Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
CC transcript
Quarterly results
Director departure
Pharmasset Inc (VRUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/12/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/13/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/09/2012 SC 13G Pharmasset Inc reports a 6% stake in PHARMASSET INC
02/02/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
01/19/2012 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/17/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
01/17/2012 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
01/17/2012 8-K Quarterly results
01/13/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2012 8-K Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O...
01/12/2012 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/27/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/22/2011 8-K Form 8-K - Current report
12/20/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/16/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Pharmasset Announces Intent to Amend QUANTUM Trial"
12/16/2011 PRN Pharmasset Announces Intent to Amend QUANTUM Trial
12/06/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/06/2011 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
12/06/2011 SC TO-T Form SC TO-T - Tender offer statement by Third Party
11/25/2011 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
11/21/2011 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
11/21/2011 8-K Form 8-K - Current report
11/21/2011 PRN The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmasset, Inc. in Connection with the Sale of the Company to Gilead Sciences, Inc.
11/21/2011 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
11/14/2011 10-K Annual Report for the period ended September 30, 2011
11/13/2011 PRN Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
11/04/2011 8-K Form 8-K - Current report
11/04/2011 PRN Pharmasset to Webcast an Investor Event from the AASLD Meeting
11/03/2011 TRN Pharmasset's CEO Hosts Shareholder Analyst Call - Conference Call Transcript
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy